Screener
Medline, Inc. MDLN Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
| (in millions) | Six months ended / June 27, 2026 | Six months ended / June 28, 2025 |
|---|---|---|
| Proceeds from lines of credit | — | 179 |
| Payment for debt issuance cost | (3) | — |
| Payment for offering costs | (4) | — |
| Payment towards Class B unit repurchases | — | (15) |
| Exercise of employee stock options | 1 | — |
| Settlement of taxes withheld on stock-based awards | (5) | — |
| Distributions to partners | — | (303) |
| Distributions to noncontrolling interests | (123) | — |
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s payments for repurchase of common stock?
- Medline, Inc. (MDLN) reported payments for repurchase of common stock of $0 in Q2 2026.
- How has Medline, Inc.'s payments for repurchase of common stock changed year-over-year?
- Medline, Inc.'s payments for repurchase of common stock decreased by 100.0% year-over-year, from $6M to $0.
- What does payments for repurchase of common stock mean?
- Payments for Repurchase of Common Stock
Ask your AI about Medline, Inc.'s payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude